MabCure, Inc.
MBCI
$0.0001
$0.000.00%
OTC PK
| 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 40.84% | 19.60% | -14.32% | -30.35% | -38.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.59% | -5.63% | -14.51% | -24.32% | -24.94% |
| Operating Income | 31.05% | 5.63% | 14.51% | 24.32% | 24.94% |
| Income Before Tax | -893.52% | 9.24% | -8.33% | 8.54% | 10.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -893.52% | 9.24% | -8.33% | 8.54% | 10.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -893.52% | 9.24% | -8.33% | 8.54% | 10.69% |
| EBIT | 31.05% | 5.63% | 14.51% | 24.32% | 24.94% |
| EBITDA | 31.33% | 5.54% | 14.97% | 25.11% | 25.95% |
| EPS Basic | -859.50% | 12.13% | -4.76% | 11.20% | 12.66% |
| Normalized Basic EPS | 31.20% | 12.08% | -4.86% | 11.92% | 12.59% |
| EPS Diluted | -859.50% | 12.13% | 8.33% | 21.90% | 23.66% |
| Normalized Diluted EPS | 31.20% | 12.08% | -4.86% | 11.92% | 12.59% |
| Average Basic Shares Outstanding | 2.09% | 2.30% | 2.72% | 3.29% | 2.81% |
| Average Diluted Shares Outstanding | 2.09% | 2.30% | 2.69% | 3.26% | 2.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |